We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-21.82%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$212M
AUM Growth
-$93.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$148M 69.78%
3,887,502
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$20.9M 9.88%
1,729,674
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.74B
$15.6M 7.34%
2,168,691
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
$11.2M 5.28%
5,736,296
ELGX
5
DELISTED
Endologix Inc
ELGX
$6.42M 3.03%
112,145
HSTO
6
DELISTED
Histogen Inc. Common Stock
HSTO
$6.28M 2.97%
5,960
TARA icon
7
Protara Therapeutics
TARA
$226M
$1.87M 0.88%
24,585
PETX
8
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.79M 0.85%
250,000

Similar funds

MPM Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, MPM Asset Management held 8 positions worth $212M, down 31% from $305M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 0%. MPM Asset Management opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's ten largest holdings make up 100% of its $212M portfolio in Q4 2016.
  • MPM Asset Management opened 0 new positions and closed 0 in Q4 2016.
  • MPM Asset Management's portfolio value fell 31% quarter-over-quarter to $212M.

Based on MPM Asset Management's 13F filing for Q4 2016, filed 7 Feb 2017.